Back | Next |
home / stock / bvxv / bvxv message board
Subject | By | Source | When |
---|---|---|---|
NetworkNewsWire: BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Releases Business Updates and Announce | NetworkNewsWire | investorshangout | 01/04/2023 9:50:24 PM |
NetworkNewsWire: NetworkNewsBreaks BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Releases Letter to | NetworkNewsWire | investorshangout | 01/03/2023 9:34:05 PM |
BiondVax CEO Issues Letter to Shareholders | midastouch017 | investorshub | 12/30/2022 1:20:29 PM |
NetworkNewsWire: NetworkNewsBreaks BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Well-Positioned to | NetworkNewsWire | investorshangout | 12/29/2022 8:20:30 PM |
Watching | Benwahsauce | investorshub | 09/11/2022 11:40:41 PM |
if you read the NEWS and can really | beambe | investorshub | 03/28/2022 4:32:52 PM |
BiondVax Announces Fourth Quarter and Full Year 2021 | midastouch017 | investorshub | 03/28/2022 12:29:37 PM |
good NEWS | beambe | investorshub | 03/28/2022 11:13:25 AM |
probably only a few really understood the news | beambe | investorshub | 03/25/2022 6:35:37 PM |
Volume: 54,275,504 @03/24/22 12:52:43 PM ED | beambe | investorshub | 03/24/2022 5:08:15 PM |
an exclusive worldwide license for $BVXV worldwide is | beambe | investorshub | 03/24/2022 5:07:38 PM |
wtf is going on? | MouthBreather | investorshub | 03/24/2022 3:23:52 PM |
What a bleed we r experiencing ! | INEEDMONEY | investorshub | 03/24/2022 3:21:30 PM |
good Volume | beambe | investorshub | 03/24/2022 1:41:13 PM |
BiondVax signs definitive collaboration agreement for the development | midastouch017 | investorshub | 03/24/2022 1:26:56 PM |
BiondVax to Present at Edison Group's Open House Conference | midastouch017 | investorshub | 01/26/2022 1:51:40 PM |
https://finance.yahoo.com/news/aegis-capital-corp-acted-sole-151500692.html BVX | Man6677 | investorshub | 01/09/2022 9:57:11 AM |
Hope for some more excellent updates here ! | Man6677 | investorshub | 12/30/2021 8:48:37 PM |
Thank you very much ;-) | Man6677 | investorshub | 12/30/2021 10:47:47 AM |
This was the real good news: | midastouch017 | investorshub | 12/30/2021 10:46:11 AM |
News, Short Squeeze, Breakout and More Instantly...
BiondVax Pharmaceuticals Ltd. Company Name:
BVXV Stock Symbol:
NASDAQ Market:
BiondVax (NASDAQ: BVXV) , a biotechnology company, today announced a change of its corporate name to Scinai Immunotherapeutics, which will debut on the Nasdaq under a new symbol, SCNI, on Sept. 7, 2023. In the past two years, the company has revamped its senior management team and pharmaceuticals...
JERUSALEM, Sept. 06, 2023 (GLOBE NEWSWIRE) -- via IBN -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV) , a biopharmaceutical company, is pleased to announce today a change of its corporate name to Scinai Immunotherapeutics Ltd. (“Scinai ”). In the past two years, the Company ...
BiondVax (NASDAQ: BVXV) , a biotechnology company that recently signed an exclusive worldwide license to develop and commercialize innovative alpaca-derived nanosized antibodies (“NanoAbs”) targeting IL-17 cytokines as treatments for psoriasis and psoriatic arthritis, recently recei...